MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $598,475 | $381,623 | $246,583 | $615,426 |
| - Cash | $223,125 | $39,781 | $29,903 | $49,351 |
| + Debt | $623 | $650 | $130 | $171 |
| Enterprise Value | $375,973 | $342,492 | $216,810 | $566,246 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$21,568 | -$21,744 | -$26,452 | -$18,552 |
| % Margin | – | – | – | – |
| Net Income | -$21,618 | -$19,411 | -$23,880 | -$15,586 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.63 | -0.58 | -0.71 | -0.47 |
| % Growth | -8.6% | 18.3% | -51.1% | – |
| Operating Cash Flow | -$21,536 | -$17,434 | -$22,678 | -$16,037 |
| Capital Expenditures | -$399 | -$707 | -$30 | -$92 |
| Free Cash Flow | -$21,935 | -$18,141 | -$22,708 | -$16,129 |